MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-05-2025
Align Technology DPO Ratio 2011-2026 | ALGN
Annual DPO Ratio Align Technology
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 33.7 | 38.1 | 48.4 | 54.9 | 59.1 | 48 | 45.2 | 37.7 | 39.4 | 85.6 | 57.7 | 46.1 | 57 | 68.8 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 85.6 | 33.7 | 51.4 |
Quarterly DPO Ratio Align Technology
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 30.7 | 36 | 35.7 | - | 33.1 | 33.3 | 35.1 | - | 32.2 | 38.1 | 41.7 | - | 23.4 | 30.2 | 60.6 | - | 70 | 63.2 | 55.8 | - | 64.8 | 101 | 66.8 | - | 46.9 | 47.3 | 47.1 | - | 43.9 | 47 | 42.1 | - | 36.2 | 39.2 | 39.9 | - | 37.6 | 40.7 | 49.4 | - | 62.6 | 61.6 | 55.9 | - | 47.3 | 45.1 | 43.1 | - | 41 | 40.3 | 41.7 | - | 49.4 | 48.4 | 51.6 | - | 52.4 | 60.7 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 101 | 23.4 | 47.1 |
DPO Ratio of other stocks in the Medical devices industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acutus Medical
AFIB
|
92.7 | - | -26.83 % | $ 2.62 M |  USA |
 |
Allied Healthcare Products
AHPI
|
23.1 | - | 3.58 % | $ 2.21 M | USA |
 |
AxoGen
AXGN
|
79.6 | $ 32.95 | 6.12 % | $ 1.46 B | USA |
 |
Abiomed
ABMD
|
76.2 | - | - | $ 17.2 B | USA |
 |
Boston Scientific Corporation
BSX
|
66 | $ 98.65 | 0.01 % | $ 145 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
81.3 | - | - | $ 1.77 B | USA |
 |
Alphatec Holdings
ATEC
|
99.4 | $ 21.97 | - | $ 3.14 B | USA |
 |
Lianluo Smart Limited
LLIT
|
10.5 | - | 24.59 % | $ 44.8 M |  China |
 |
Axonics Modulation Technologies
AXNX
|
40.1 | - | - | $ 3.31 B | USA |
 |
Apyx Medical Corporation
APYX
|
52.8 | $ 3.46 | -2.81 % | $ 120 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
224 | - | -5.86 % | $ 30.6 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
81.1 | $ 9.54 | 2.03 % | $ 685 M |  Israel |
 |
Bio-Rad Laboratories
BIO
|
41 | $ 324.09 | -0.43 % | $ 9.14 B | USA |
 |
Apollo Endosurgery
APEN
|
63.6 | - | - | $ 475 M | USA |
 |
Conformis
CFMS
|
50.4 | - | - | $ 16.4 M | USA |
 |
Bruker Corporation
BRKR
|
46.4 | $ 53.01 | - | $ 7.9 K | USA |
 |
CONMED Corporation
CNMD
|
60.6 | $ 43.4 | -0.05 % | $ 1.34 B | USA |
 |
Abbott Laboratories
ABT
|
82.8 | $ 127.04 | - | $ 221 B | USA |
 |
EDAP TMS S.A.
EDAP
|
40.6 | $ 3.8 | 0.53 % | $ 142 M |  France |
 |
Electromed
ELMD
|
47.8 | $ 29.4 | - | $ 249 M | USA |
 |
Cardiovascular Systems
CSII
|
81.8 | - | 0.15 % | $ 844 M | USA |
 |
CryoLife, Inc.
CRY
|
41.1 | - | -4.14 % | $ 702 M | USA |
 |
Cutera
CUTR
|
57.2 | - | -10.19 % | $ 1.99 M | USA |
 |
InMode Ltd.
INMD
|
65.1 | $ 15.64 | - | $ 1.24 B | Israel |
 |
CHF Solutions, Inc.
CHFS
|
204 | - | 1.15 % | $ 34.5 M | USA |
 |
Eargo
EAR
|
124 | - | - | $ 10.2 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
131 | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
83.1 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
48.6 | - | - | $ 111 M |  Canada |
 |
Second Sight Medical Products
EYES
|
21 | - | -0.97 % | $ 54.4 M | USA |
 |
Dynatronics Corporation
DYNT
|
52.2 | - | 14.99 % | $ 929 K | USA |
 |
Intersect ENT, Inc.
XENT
|
72.8 | - | - | $ 955 M | USA |
 |
IRIDEX Corporation
IRIX
|
50.7 | $ 1.19 | 0.85 % | $ 19.2 M | USA |
 |
IRadimed Corporation
IRMD
|
40.6 | $ 98.34 | 0.28 % | $ 1.25 B | USA |
 |
Accuray Incorporated
ARAY
|
49.2 | $ 0.87 | - | $ 89.4 M | USA |
 |
Avinger
AVGR
|
45.5 | - | -20.74 % | $ 369 K | USA |
 |
ClearPoint Neuro
CLPT
|
25.8 | $ 15.29 | - | $ 413 M | USA |
 |
FONAR Corporation
FONR
|
16.6 | $ 18.54 | - | $ 122 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
70.1 | $ 18.39 | -1.87 % | $ 424 M | USA |
 |
Globus Medical
GMED
|
23.2 | $ 90.54 | - | $ 12.3 B | USA |
 |
LivaNova PLC
LIVN
|
71.8 | $ 64.62 | 0.78 % | $ 3.5 B |  Britain |
|
LENSAR
LNSR
|
66 | $ 11.53 | 0.7 % | $ 133 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
43.8 | $ 13.15 | 0.15 % | $ 1.01 B | USA |
 |
Aziyo Biologics
AZYO
|
48.8 | - | 1.37 % | $ 20.5 M | USA |
 |
Establishment Labs Holdings
ESTA
|
279 | $ 70.01 | - | $ 1.97 B |  Costa-rica |